Investigation of the Effect of Cognitive Behavioral Approach-Based Psychoeducation

Substance Use Disorders Clinical Trial

Official title:

Investigation of the Effect of Cognitive Behavioral Approach-Based Psychoeducation on Addiction Profile, Self-efficacy and Addiction Course in Substance Use Disorder Randomized Controlled Experimental Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05941195
• Other study ID #: Adnan MU
• Status: Completed
• Phase: N/A
• Start date: December 1, 2022
• Est. completion date: May 30, 2023

Study information

• Verified date: July 2023
• Source: Aydin Adnan Menderes University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study, which was planned to examine the effects of cognitive behavioral approach-based psychoeducation on addiction profiles, self-efficacy levels and addiction courses in patients with substance use disorders, was carried out as a randomized controlled experimental study.

Description:

It can be said that alcohol/substance nurses, by applying cognitive behavioral approach-based psychoeducation to patients with substance use disorders, can have a positive effect on reducing the severity of addiction, increasing their self-efficacy levels, and providing the care, education and counseling support that patients need. The aim of this study is to examine the effects of cognitive behavioral approach-based psychoeducation applied to patients with substance use disorder on addiction profiles, self-efficacy levels and addiction courses.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: May 30, 2023
• Est. primary completion date: February 28, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

1. To be diagnosed with "Substance Use Disorder" according to The Diagnostic and Statistical Manual of Mental Disorders-V,

2. To be over 18 years old,

3. Volunteering to participate in the research.

Exclusion Criteria:

1. Other than Substance Use Disorder, chronic, requiring ongoing help and care the presence of a medical illness,

2. Being illiterate (the types of scales to be used must be self-report forms) because of).

Related Conditions & MeSH terms

• Addiction
• Behavior, Addictive
• Self Efficacy
• Substance Use Disorders
• Substance-Related Disorders

Intervention

Other:
• Psychoeducation
In the cognitive behavioral approach based psychoeducation given to the experimental group patients; "Addiction and Its Effects", "Increasing and Maintaining Motivation", "The Cognitive Model and the Cognitive Model of Addiction", "Automatic Thoughts That Increase Impulse to Substance Use", "Dysfunctional Beliefs Regarding Substance Use", "High Risk Situations and Coping Skills", " The topics of "Prevention of Slippage and Recurrence" and "Problem Solving" are included.

Locations

Country	Name	City	State
Turkey	Aydin Adnan Menderes University Faculy of Nursing, Division Mental HealthNursing	Aydin

Sponsors (1)

Lead Sponsor	Collaborator
Aydin Adnan Menderes University

Country where clinical trial is conducted

Turkey, 

References & Publications (4)

Gözüm S, Aksayan S. Öz-etkililik-yeterlik ölçegi'nin türkçe formunun güvenilirlik ve geçerliligi. Anadolu Hemsirelik ve Saglik Bilimleri Dergisi. 1999; 2(1): 21-34.

Ögel K, Koç C, Basabak A, Ismen EM, Görücü S. Bagimlilik profil indeksi klinik formunun (BAPI-K) gelistirilmesi: Geçerlik ve güvenilirlik Çalismasi. Bagimlilik Dergisi.2015; 16(2), 57-69.

Sherer M, Maddux JE, Mercandante B, Prentice-Dunn S, Jacobs B, Rogers R W. The self-efficacy scale: Construction and validation. Psychological reports.1982; 51(2), 663-671.

Simsek M, Dinc M, Ogel K. The Validity aand Reliability of the Addiction Outcome Assessment Index (AOAI). Turk Psikiyatri Derg. 2021 Summer;32(2):129-136. doi: 10.5080/u23461. English, Turkish. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Addiction Profile Index (Bapi) Clinical Form	Addiction Profile Index Clinical Form was created by adding 21 questions to the Addiction Profile Index developed in 2012 to measure the severity of addiction. It consists of 58 questions in total and has 11 sub-dimensions. It evaluates different dimensions of addictions of alcohol and substance users. Two of the six domains of the scale measure mental state, while the others measure some personal characteristics related to addiction .	The first measurement was made in the 1st week.
Primary	Addiction Profile Index (Bapi) Clinical Form	Addiction Profile Index Clinical Form was created by adding 21 questions to the Addiction Profile Index developed in 2012 to measure the severity of addiction. It consists of 58 questions in total and has 11 sub-dimensions. It evaluates different dimensions of addictions of alcohol and substance users. Two of the six domains of the scale measure mental state, while the others measure some personal characteristics related to addiction.	The last measurement was made at the 5th week.
Primary	Addiction Outcome Assessment Index (AOAI)	The Addiction Outcome Index (BASI) was developed to measure the treatment course and recovery level of addiction in all areas and to be used in follow-up. The score that can be obtained from the scale is between 0-32. A decrease of 3.5 points from the total score of the scale in clinical follow-up indicates a reliable change .	The first measurement was made in the 1st week.
Primary	Addiction Outcome Assessment Index (AOAI)	The Addiction Outcome Index (BASI) was developed to measure the treatment course and recovery level of addiction in all areas and to be used in follow-up. The score that can be obtained from the scale is between 0-32. A decrease of 3.5 points from the total score of the scale in clinical follow-up indicates a reliable change .	The last measurement was made at the 5th week.
Primary	Self-Efficacy Scale (SES)	The scale was first developed in the English language in 1982. It was adapted into Turkish in 1999 and follows the course of self-efficacy expectations that need to be changed in individual therapy during the therapy process. The Self-Efficacy Scale consists of 23 items and 4 sub-factors. A minimum of 23 and a maximum of 115 points can be obtained from the scale. A high total score from the scale indicates that the individual's self-efficacy perception is at a good level.	The first measurement was made in the 1st week.
Primary	Self-Efficacy Scale (SES)	The scale was first developed in the English language in 1982 . It was adapted into Turkish in 1999 and follows the course of self-efficacy expectations that need to be changed in individual therapy during the therapy process. The Self-Efficacy Scale consists of 23 items and 4 sub-factors. A minimum of 23 and a maximum of 115 points can be obtained from the scale. A high total score from the scale indicates that the individual's self-efficacy perception is at a good level.	The last measurement was made at the 5th week.